Full name :
First name :
Mail :
Zip Code :
City :
Country :
Email :
Phone :
Fax :
Website :
Directory :
| Title : The soluble epoxide hydrolase inhibitor GSK2256294 decreases the proportion of adipose pro-inflammatory T cells - Mashayekhi_2021_Prostaglandins.Other.Lipid.Mediat_158_106604 |
| Author(s) : Mashayekhi M , Wanjalla CN , Warren CM , Simmons JD , Ghoshal K , Pilkinton M , Bailin SS , Gabriel CL , Pozzi A , Koethe JR , Brown NJ , Kalams SA , Luther JM |
| Ref : Prostaglandins Other Lipid Mediat , 158 :106604 , 2021 |
| Abstract : Mashayekhi_2021_Prostaglandins.Other.Lipid.Mediat_158_106604 |
| ESTHER : Mashayekhi_2021_Prostaglandins.Other.Lipid.Mediat_158_106604 |
| PubMedSearch : Mashayekhi_2021_Prostaglandins.Other.Lipid.Mediat_158_106604 |
| PubMedID: 34922004 |
| Title : GSK2256294 Decreases sEH (Soluble Epoxide Hydrolase) Activity in Plasma, Muscle, and Adipose and Reduces F2-Isoprostanes but Does Not Alter Insulin Sensitivity in Humans - |
| Author(s) : Luther JM , Ray J , Wei D , Koethe JR , Hannah L , DeMatteo A , Manning R , Terker AS , Peng D , Nian H , Yu C , Mashayekhi M , Gamboa J , Brown NJ |
| Ref : Hypertension , 78 :1092 , 2021 |
| PubMedID: 34455816 |
| Title : Arg287Gln variant of EPHX2 and epoxyeicosatrienoic acids are associated with insulin sensitivity in humans - Ramirez_2014_Prostaglandins.Other.Lipid.Mediat_113-115_38 |
| Author(s) : Ramirez CE , Shuey MM , Milne GL , Gilbert K , Hui N , Yu C , Luther JM , Brown NJ |
| Ref : Prostaglandins Other Lipid Mediat , 113-115 :38 , 2014 |
| Abstract : Ramirez_2014_Prostaglandins.Other.Lipid.Mediat_113-115_38 |
| ESTHER : Ramirez_2014_Prostaglandins.Other.Lipid.Mediat_113-115_38 |
| PubMedSearch : Ramirez_2014_Prostaglandins.Other.Lipid.Mediat_113-115_38 |
| PubMedID: 25173047 |
| Gene_locus related to this paper: human-EPHX2 |
| Title : Genetic variation in soluble epoxide hydrolase (EPHX2) is associated with forearm vasodilator responses in humans - Lee_2011_Hypertension_57_116 |
| Author(s) : Lee CR , Pretorius M , Schuck RN , Burch LH , Bartlett J , Williams SM , Zeldin DC , Brown NJ |
| Ref : Hypertension , 57 :116 , 2011 |
| Abstract : Lee_2011_Hypertension_57_116 |
| ESTHER : Lee_2011_Hypertension_57_116 |
| PubMedSearch : Lee_2011_Hypertension_57_116 |
| PubMedID: 21098312 |
| Title : Interactive hemodynamic effects of dipeptidyl peptidase-IV inhibition and angiotensin-converting enzyme inhibition in humans - Marney_2010_Hypertension_56_728 |
| Author(s) : Marney A , Kunchakarra S , Byrne L , Brown NJ |
| Ref : Hypertension , 56 :728 , 2010 |
| Abstract : Marney_2010_Hypertension_56_728 |
| ESTHER : Marney_2010_Hypertension_56_728 |
| PubMedSearch : Marney_2010_Hypertension_56_728 |
| PubMedID: 20679179 |
| Title : Dipeptidyl peptidase IV in angiotensin-converting enzyme inhibitor associated angioedema - Byrd_2008_Hypertension_51_141 |
| Author(s) : Byrd JB , Touzin K , Sile S , Gainer JV , Yu C , Nadeau J , Adam A , Brown NJ |
| Ref : Hypertension , 51 :141 , 2008 |
| Abstract : Byrd_2008_Hypertension_51_141 |
| ESTHER : Byrd_2008_Hypertension_51_141 |
| PubMedSearch : Byrd_2008_Hypertension_51_141 |
| PubMedID: 18025295 |
| Title : Dipeptidyl peptidase IV deficiency increases susceptibility to angiotensin-converting enzyme inhibitor-induced peritracheal edema - Byrd_2007_J.Allergy.Clin.Immunol_120_403 |
| Author(s) : Byrd JB , Shreevatsa A , Putlur P , Foretia D , McAlexander L , Sinha T , Does MD , Brown NJ |
| Ref : J Allergy Clin Immunol , 120 :403 , 2007 |
| Abstract : Byrd_2007_J.Allergy.Clin.Immunol_120_403 |
| ESTHER : Byrd_2007_J.Allergy.Clin.Immunol_120_403 |
| PubMedSearch : Byrd_2007_J.Allergy.Clin.Immunol_120_403 |
| PubMedID: 17531305 |